A detailed history of Diversified Enterprises, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Diversified Enterprises, LLC holds 7,004 shares of AZN stock, worth $626,157. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,004
Previous 6,964 0.57%
Holding current value
$626,157
Previous $487 Million 10.41%
% of portfolio
0.04%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 10, 2025

BUY
$68.72 - $82.11 $2,748 - $3,284
40 Added 0.57%
7,004 $537 Million
Q2 2025

Jul 16, 2025

SELL
$64.87 - $75.0 $35,419 - $40,950
-546 Reduced 7.27%
6,964 $487 Million
Q1 2025

May 15, 2025

BUY
$65.37 - $77.96 $216,243 - $257,891
3,308 Added 78.72%
7,510 $552 Million
Q4 2024

Feb 10, 2025

SELL
$63.2 - $79.58 $2,970 - $3,740
-47 Reduced 1.11%
4,202 $275 Million
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $325,770 - $372,297
4,249 New
4,249 $331 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $277B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Diversified Enterprises, LLC Portfolio

Follow Diversified Enterprises, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Enterprises, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Enterprises, LLC with notifications on news.